This site may require a log-in in the near future. We are constantly being swamped by AI agents. If they continue to take down the site, we will be changing to requiring logins to access any item.

🍽️ pargyline hydrochloride,(prescription)

AI Engines For more Details: PerplexityKagi LabsYou

  1. Parkinson's Disease: Pargyline hydrochloride is used as an adjunctive therapy in the management of Parkinson's disease, a neurodegenerative disorder characterized by movement difficulties, tremors, muscle stiffness, and impaired balance. It works by inhibiting the activity of monoamine oxidase (MAO), an enzyme that breaks down dopamine in the brain. By inhibiting MAO, pargyline hydrochloride increases dopamine levels, which can help alleviate some of the motor symptoms associated with Parkinson's disease.

  2. Depression: Pargyline hydrochloride has also been used in the treatment of certain types of depression, particularly those that are characterized by atypical features or refractory to other antidepressant medications. It is thought to exert its antidepressant effects by increasing levels of monoamine neurotransmitters such as serotonin, dopamine, and norepinephrine in the brain.

  3. Side Effects: Like other MAOIs, pargyline hydrochloride can cause a range of side effects, some of which can be severe. Common side effects may include dizziness, drowsiness, headache, nausea, dry mouth, constipation, and changes in appetite or weight. More serious side effects may include hypertensive crisis (dangerously high blood pressure), serotonin syndrome (excessive serotonin levels), and interactions with certain foods, beverages, and medications. It's essential to discuss potential side effects with your healthcare provider before starting treatment with pargyline hydrochloride.

  4. Hypertensive Crisis: One of the most significant risks associated with MAOIs like pargyline hydrochloride is the potential to cause hypertensive crisis, a sudden and severe increase in blood pressure that can lead to life-threatening complications such as stroke, heart attack, or organ damage. To avoid this risk, individuals taking pargyline hydrochloride must adhere to a strict dietary regimen that avoids tyramine-rich foods (such as aged cheeses, cured meats, certain fruits, and alcoholic beverages) and avoid certain medications that can interact with MAOIs.

  5. Serotonin Syndrome: Pargyline hydrochloride can also increase the risk of serotonin syndrome, a potentially life-threatening condition characterized by symptoms such as agitation, hallucinations, confusion, rapid heart rate, elevated body temperature, sweating, tremors, and muscle rigidity. Serotonin syndrome is most likely to occur when MAOIs are used in combination with other medications that increase serotonin levels, such as selective serotonin reuptake inhibitors (SSRIs), serotonin-norepinephrine reuptake inhibitors (SNRIs), or certain opioids.

  6. Drug Interactions: Pargyline hydrochloride can interact with a wide range of medications, including other antidepressants, sympathomimetic agents, antihypertensive drugs, certain pain medications, and medications that affect serotonin or dopamine levels. It's essential to inform your healthcare provider about all medications, supplements, and herbal products you are taking before starting treatment with pargyline hydrochloride.

  7. Pregnancy and Breastfeeding: The safety of pargyline hydrochloride during pregnancy and breastfeeding has not been well-established. It is generally not recommended for use during pregnancy unless the potential benefits outweigh the risks. Women who are pregnant or breastfeeding should discuss the risks and benefits of treatment with their healthcare provider.

  8. Liver and Kidney Function: Pargyline hydrochloride should be used with caution in individuals with impaired liver or kidney function, as dosage adjustments may be necessary based on the severity of impairment.

  9. Psychiatric Monitoring: Individuals taking pargyline hydrochloride for depression should be closely monitored by their healthcare provider for changes in mood, behavior, or suicidal thoughts, particularly during the initial stages of treatment or when adjusting the dosage.

;

Check for interactions on Supp.AI   |   πŸ“š PubMed Citations

βš—οΈ Compensation for antibiotic usage

Data Contradictions β€” Limits of Certainity

Impacted of pargyline hydrochloride,(prescription) On Probiotics

Rank Probiotic Impact
genus Bifidobacterium Reduces
species Akkermansia muciniphila Reduces
species Anaerobutyricum hallii Reduces
species Bifidobacterium adolescentis Reduces
species Bifidobacterium breve Reduces
species Bifidobacterium catenulatum Reduces
species Bifidobacterium longum Reduces
species Escherichia coli Reduces
species Lacticaseibacillus paracasei Reduces
species Parabacteroides distasonis Reduces
subspecies Bifidobacterium longum subsp. infantis Reduces
subspecies Bifidobacterium longum subsp. longum Reduces

Bacteria Impacted by pargyline hydrochloride,(prescription)

We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.

πŸ§™?

πŸ““ Direct Citations πŸ‘ͺπŸ‘Ά Indirect Citations Taxonomy Rank Effect
0 1 Akkermansiaceae family Decreases
0 1 Thomasclavelia genus Decreases
0 1 Eggerthella genus Decreases
0 1 Escherichia genus Decreases
0 1 Roseburia genus Decreases
0 1 Lacrimispora genus Decreases
0 1 Bifidobacterium genus Decreases
0 1 Mediterraneibacter genus Decreases
0 1 Blautia genus Decreases
0 1 Shigella genus Decreases
0 1 Collinsella genus Decreases
0 1 Coprococcus genus Decreases
0 1 Bacteroides genus Decreases
0 1 Lacticaseibacillus genus Decreases
0 1 Agathobacter genus Decreases
0 1 Veillonella genus Decreases
0 1 Lachnospira genus Decreases
0 1 Parabacteroides genus Decreases
0 1 Ruminococcus genus Decreases
1 0 Akkermansia genus Decreases
0 1 Clostridium genus Decreases
0 1 Odoribacter genus Decreases
0 1 Dorea genus Decreases
0 1 Escherichia coli O1:K1:H7 no rank Decreases
0 1 Escherichia coli O139:H1 no rank Decreases
0 1 Escherichia coli O141:H4 no rank Decreases
0 1 Escherichia coli O145:H34 no rank Decreases
0 1 Escherichia coli O15:H12 no rank Decreases
0 1 Escherichia coli O155:H21 no rank Decreases
0 1 Escherichia coli O158:H23 no rank Decreases
0 1 Escherichia coli O16:H48 no rank Decreases
0 1 Escherichia coli O170:H18 no rank Decreases
0 1 Escherichia coli O18ac:H14 no rank Decreases
0 1 Escherichia coli O19:H7 no rank Decreases
0 1 Escherichia coli O2:K1:H4 no rank Decreases
0 1 Escherichia coli O2:K1:H5 no rank Decreases
0 1 Escherichia coli O2:K1:H7 no rank Decreases
0 1 Escherichia coli O20:H12 no rank Decreases
0 1 Escherichia coli O25:H16 no rank Decreases
0 1 Escherichia coli O55:H7 no rank Decreases
0 1 Escherichia coli O68:H12 no rank Decreases
0 1 Escherichia coli O7:H15 no rank Decreases
0 1 Escherichia coli O78:H51 no rank Decreases
0 1 Escherichia coli O80:H26 no rank Decreases
0 1 Escherichia coli O84:H7 no rank Decreases
0 1 Escherichia coli O85:H1 no rank Decreases
0 1 Clostridium perfringens A no rank Decreases
0 1 Clostridium perfringens B no rank Decreases
0 1 Clostridium perfringens C no rank Decreases
0 1 Clostridium perfringens CPE no rank Decreases
0 1 Clostridium perfringens D no rank Decreases
0 1 Clostridium perfringens E no rank Decreases
0 1 environmental samples no rank Decreases
0 1 unclassified Akkermansia no rank Decreases
0 1 Escherichia coli O103 serogroup Decreases
0 1 Escherichia coli O111 serogroup Decreases
0 1 Escherichia coli O119 serogroup Decreases
0 1 Escherichia coli O121 serogroup Decreases
0 1 Escherichia coli O145 serogroup Decreases
0 1 Escherichia coli O155 serogroup Decreases
0 1 Escherichia coli O157 serogroup Decreases
0 1 Escherichia coli O177 serogroup Decreases
0 1 Escherichia coli O26 serogroup Decreases
0 1 Escherichia coli O3 serogroup Decreases
0 1 Escherichia coli O43 serogroup Decreases
0 1 Escherichia coli O5 serogroup Decreases
0 1 Escherichia coli O78 serogroup Decreases
0 1 Escherichia coli O86 serogroup Decreases
0 1 Escherichia coli O91 serogroup Decreases
0 1 Escherichia coli H20 serotype Decreases
0 1 Escherichia coli O1:H42 serotype Decreases
0 1 Escherichia coli O1:HNT serotype Decreases
0 1 Escherichia coli O10:H32 serotype Decreases
0 1 Escherichia coli O10:K5(L):H4 serotype Decreases
0 1 Escherichia coli O100:H21 serotype Decreases
0 1 Escherichia coli O103:H11 serotype Decreases
0 1 Escherichia coli O103:H2 serotype Decreases
0 1 Escherichia coli O103:H25 serotype Decreases
0 1 Escherichia coli O104:H21 serotype Decreases
0 1 Escherichia coli O104:H4 serotype Decreases
0 1 Escherichia coli O111:H- serotype Decreases
0 1 Escherichia coli O111:H11 serotype Decreases
0 1 Escherichia coli O111:H8 serotype Decreases
0 1 Escherichia coli O111:NM serotype Decreases
0 1 Escherichia coli O112ab:H8 serotype Decreases
0 1 Escherichia coli O112ac:H19 serotype Decreases
0 1 Escherichia coli O113:H21 serotype Decreases
0 1 Escherichia coli O114:H49 serotype Decreases
0 1 Escherichia coli O118:H16 serotype Decreases
0 1 Escherichia coli O121:H19 serotype Decreases
0 1 Escherichia coli O121:H7 serotype Decreases
0 1 Escherichia coli O123:H11 serotype Decreases
0 1 Escherichia coli O125ac:K+:H10 serotype Decreases
0 1 Escherichia coli O126:H45 serotype Decreases
0 1 Escherichia coli O127:H27 serotype Decreases
0 1 Escherichia coli O127:H6 serotype Decreases
0 1 Escherichia coli O128:H2 serotype Decreases
0 1 Escherichia coli O128ac:H12 serotype Decreases
0 1 Escherichia coli O139:H28 serotype Decreases
0 1 Escherichia coli O145:H25 serotype Decreases
0 1 Escherichia coli O145:H28 serotype Decreases
0 1 Escherichia coli O145:NM serotype Decreases
0 1 Escherichia coli O146:H21 serotype Decreases
0 1 Escherichia coli O15:H18 serotype Decreases
0 1 Escherichia coli O150:H6 serotype Decreases
0 1 Escherichia coli O152:H23 serotype Decreases
0 1 Escherichia coli O153:H2 serotype Decreases
0 1 Escherichia coli O156:H25 serotype Decreases
0 1 Escherichia coli O157:H- serotype Decreases
0 1 Escherichia coli O157:H43 serotype Decreases
0 1 Escherichia coli O157:H7 serotype Decreases
0 1 Escherichia coli O157:NM serotype Decreases
0 1 Escherichia coli O16:H6 serotype Decreases
0 1 Escherichia coli O165:H25 serotype Decreases
0 1 Escherichia coli O167:H26 serotype Decreases
0 1 Escherichia coli O174:H2 serotype Decreases
0 1 Escherichia coli O174:H21 serotype Decreases
0 1 Escherichia coli O174:H8 serotype Decreases
0 1 Escherichia coli O176:H45 serotype Decreases
0 1 Escherichia coli O177:NM serotype Decreases
0 1 Escherichia coli O2:H6 serotype Decreases
0 1 Escherichia coli O2:K2:H1 serotype Decreases
0 1 Escherichia coli O25:H1 serotype Decreases
0 1 Escherichia coli O25:NM serotype Decreases
0 1 Escherichia coli O26:H1 serotype Decreases
0 1 Escherichia coli O26:H11 serotype Decreases
0 1 Escherichia coli O28ac:NM serotype Decreases
0 1 Escherichia coli O29:H4 serotype Decreases
0 1 Escherichia coli O32:H37 serotype Decreases
0 1 Escherichia coli O39:NM serotype Decreases
0 1 Escherichia coli O44:H18 serotype Decreases
0 1 Escherichia coli O45:H2 serotype Decreases
0 1 Escherichia coli O6:H16 serotype Decreases
0 1 Escherichia coli O6:H16:CFA/II serotype Decreases
0 1 Escherichia coli O6:K2:H1 serotype Decreases
0 1 Escherichia coli O69:H11 serotype Decreases
0 1 Escherichia coli O7:H4 serotype Decreases
0 1 Escherichia coli O7:K1 serotype Decreases
0 1 Escherichia coli O78:H12 serotype Decreases
0 1 Escherichia coli O78:H4 serotype Decreases
0 1 Escherichia coli O79:H7 serotype Decreases
0 1 Escherichia coli O8:H8 serotype Decreases
0 1 Escherichia coli O81:NM serotype Decreases
0 1 Escherichia coli O83:H1 serotype Decreases
0 1 Escherichia coli O86:H34 serotype Decreases
0 1 Escherichia coli O89m:H10 serotype Decreases
0 1 Escherichia coli O89m:H9 serotype Decreases
0 1 Escherichia coli O9:H10 serotype Decreases
0 1 Escherichia coli O91:H14 serotype Decreases
0 1 Escherichia coli O91:NM serotype Decreases
0 1 Escherichia coli O99:H6 serotype Decreases
0 1 Escherichia coli ONT:H33 serotype Decreases
1 0 Eggerthella lenta species Decreases
1 0 Thomasclavelia ramosa species Decreases
1 0 Escherichia coli species Decreases
1 0 Roseburia hominis species Decreases
1 0 Bifidobacterium longum species Decreases
1 0 Lacrimispora saccharolytica species Decreases
1 0 [Ruminococcus] torques species Decreases
1 0 Bifidobacterium adolescentis species Decreases
1 0 Bacteroides xylanisolvens species Decreases
1 0 Blautia obeum species Decreases
1 0 Collinsella aerofaciens species Decreases
1 0 Coprococcus comes species Decreases
1 0 Bacteroides ovatus species Decreases
0 1 Shigella dysenteriae species Decreases
1 0 Lacticaseibacillus paracasei species Decreases
0 1 Shigella flexneri species Decreases
0 1 Escherichia albertii species Decreases
0 1 Eggerthella guodeyinii species Decreases
0 1 Escherichia fergusonii species Decreases
1 0 Agathobacter rectalis species Decreases
0 1 Shigella boydii species Decreases
0 1 Bifidobacterium breve species Decreases
1 0 Bacteroides thetaiotaomicron species Decreases
1 0 Veillonella parvula species Decreases
0 1 Bifidobacterium angulatum species Decreases
0 1 Coprococcus catus species Decreases
0 1 Shigella sonnei species Decreases
1 0 Lachnospira eligens species Decreases
0 1 Anaerobutyricum hallii species Decreases
0 1 Escherichia marmotae species Decreases
0 1 Bacteroides luhongzhouii species Decreases
0 1 Dorea longicatena species Decreases
0 1 Komagataeibacter oboediens species Decreases
0 1 Escherichia sp. E4742 species Decreases
0 1 Blautia sp. SC05B48 species Decreases
0 1 Blautia argi species Decreases
0 1 Wansuia hejianensis species Decreases
1 0 Parabacteroides distasonis species Decreases
0 1 Butyrivibrio crossotus species Decreases
0 1 Ligilactobacillus ruminis species Decreases
0 1 Parolsenella catena species Decreases
0 1 Clostridium sp. M62/1 species Decreases
0 1 Blautia liquoris species Decreases
0 1 Eubacterium ventriosum species Decreases
0 1 Subdoligranulum variabile species Decreases
0 1 Clostridium sp. SY8519 species Decreases
0 1 Qiania dongpingensis species Decreases
0 1 Faecalitalea cylindroides species Decreases
0 1 Parolsenella massiliensis species Decreases
0 1 Novisyntrophococcus fermenticellae species Decreases
0 1 Faecalibacterium duncaniae species Decreases
0 1 Bifidobacterium catenulatum species Decreases
0 1 Bacteroides sp. D2 species Decreases
0 1 [Ruminococcus] lactaris species Decreases
0 1 Mediterraneibacter gnavus species Decreases
0 1 Massilistercora timonensis species Decreases
0 1 Eubacterium sp. MSJ-33 species Decreases
1 0 Ruminococcus bromii species Decreases
1 0 Akkermansia muciniphila species Decreases
1 0 Clostridium perfringens species Decreases
1 0 Odoribacter splanchnicus species Decreases
0 1 Akkermansia glycaniphila species Decreases
0 1 Akkermansia massiliensis species Decreases
0 1 Candidatus Akkermansia intestinavium species Decreases
1 0 Dorea formicigenerans species Decreases
0 1 Bifidobacterium longum subsp. infantis subspecies Decreases
0 1 Bifidobacterium longum subsp. longum subspecies Decreases
0 1 Bifidobacterium longum subsp. suillum subspecies Decreases
0 1 Bifidobacterium longum subsp. suis subspecies Decreases
0 1 Lacticaseibacillus paracasei subsp. paracasei subspecies Decreases
0 1 Lacticaseibacillus paracasei subsp. tolerans subspecies Decreases

Impact of pargyline hydrochloride,(prescription) on Conditions from US National Library of Medicine

A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.

We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive   X|increases + Y|decrease = Negative.

Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.

Condition Positive Impact Negative Impact Benefit Ratio Impact
Abdominal Aortic Aneurysm 0.2 0.2
Acne 0.2 -0.2
ADHD 2.1 0.6 2.5
Age-Related Macular Degeneration and Glaucoma 0.4 0.1 3
Allergic Rhinitis (Hay Fever) 1.1 1.9 -0.73
Allergies 3.7 1.1 2.36
Allergy to milk products 1.3 0.9 0.44
Alopecia (Hair Loss) 0.5 0.5
Alzheimer's disease 2.1 3.1 -0.48
Amyotrophic lateral sclerosis (ALS) Motor Neuron 1.2 0.7 0.71
Ankylosing spondylitis 2.2 0.4 4.5
Anorexia Nervosa 0.6 0.9 -0.5
Antiphospholipid syndrome (APS) 0.8 0.8
Asthma 2.9 1.3 1.23
Atherosclerosis 1.2 0.4 2
Atrial fibrillation 1.1 1.1 0
Autism 3.6 4.1 -0.14
Autoimmune Disease 0.7 0.6 0.17
Barrett esophagus cancer 0.1 0.1
benign prostatic hyperplasia 0.5 0.1 4
Biofilm 0.8 0.8
Bipolar Disorder 1.1 0.9 0.22
Brain Trauma 0.4 0.7 -0.75
Breast Cancer 0.6 0.6
Cancer (General) 0.1 1.5 -14
Carcinoma 1.5 0.9 0.67
Celiac Disease 1.2 1.5 -0.25
Cerebral Palsy 0.6 0.7 -0.17
Chronic Fatigue Syndrome 2.9 2.3 0.26
Chronic Kidney Disease 2 1.6 0.25
Chronic Lyme 0.4 -0.4
Chronic Obstructive Pulmonary Disease (COPD) 0.8 0.6 0.33
Chronic Urticaria (Hives) 1 0.1 9
Coagulation / Micro clot triggering bacteria 1.1 0.5 1.2
Cognitive Function 0.7 0.6 0.17
Colorectal Cancer 2.7 1.7 0.59
Constipation 0.7 0.5 0.4
Coronary artery disease 1.6 1.3 0.23
COVID-19 5.8 4.9 0.18
Crohn's Disease 3.4 2.1 0.62
Cushing's Syndrome (hypercortisolism) 0.1 -0.1
cystic fibrosis 0.9 1.3 -0.44
d-lactic acidosis (one form of brain fog) 0.6 0.6
deep vein thrombosis 1.3 0.5 1.6
Denture Wearers Oral Shifts 0.2 0.2
Depression 5.4 5 0.08
Dermatomyositis 0.2 -0.2
Eczema 0.7 0.7 0
Endometriosis 1.9 1.3 0.46
Eosinophilic Esophagitis 0.1 -0.1
Epilepsy 1.9 0.8 1.37
erectile dysfunction 0.7 0.2 2.5
Fibromyalgia 1.7 0.8 1.13
Functional constipation / chronic idiopathic constipation 2.7 1.6 0.69
gallstone disease (gsd) 1.4 0.6 1.33
Gastroesophageal reflux disease (Gerd) including Barrett's esophagus 0.1 0.6 -5
Generalized anxiety disorder 2 1.2 0.67
giant cell arteritis 0 0
Gout 0.6 0.4 0.5
Graves' disease 0.8 1.2 -0.5
Gulf War Syndrome 0.4 0.6 -0.5
Halitosis 0.2 0.2
Hashimoto's thyroiditis 1.6 0.9 0.78
Heart Failure 1.8 1.2 0.5
hemorrhagic stroke 0.1 0.1
Hidradenitis Suppurativa 0.2 0.1 1
High Histamine/low DAO 1 0.3 2.33
hypercholesterolemia (High Cholesterol) 0.6 0.1 5
hyperglycemia 1.3 0.8 0.63
Hyperlipidemia (High Blood Fats) 0.5 0.2 1.5
hypersomnia 0.4 -0.4
hypertension (High Blood Pressure 2 3 -0.5
Hypothyroidism 0 0.9 0
Hypoxia 0.6 0.6
IgA nephropathy (IgAN) 0.6 1.6 -1.67
Inflammatory Bowel Disease 5 4.5 0.11
Insomnia 0.8 1.1 -0.38
Intelligence 0.9 0.9
Intracranial aneurysms 0.5 0.4 0.25
Irritable Bowel Syndrome 3.4 1.8 0.89
ischemic stroke 1.9 1 0.9
Liver Cirrhosis 3.4 1.8 0.89
Long COVID 3.3 4 -0.21
Low bone mineral density 0.6 -0.6
Lung Cancer 0.5 0.5 0
Lymphoma 0.5 0.5
Mast Cell Issues / mastitis 0.5 0.5 0
ME/CFS with IBS 0 1.6 0
ME/CFS without IBS 1.2 0.7 0.71
Menopause 1.4 0.3 3.67
Metabolic Syndrome 3.4 3.3 0.03
Mood Disorders 4.9 4.5 0.09
multiple chemical sensitivity [MCS] 0.1 0.2 -1
Multiple Sclerosis 3.1 1.7 0.82
Multiple system atrophy (MSA) 0.7 0.5 0.4
myasthenia gravis 0.5 0.3 0.67
neuropathic pain 0.3 1.4 -3.67
Neuropathy (all types) 0.6 0.7 -0.17
neuropsychiatric disorders (PANDAS, PANS) 0.6 0.6
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic 3.1 3 0.03
NonCeliac Gluten Sensitivity 1.2 0.4 2
Obesity 4.7 3.2 0.47
obsessive-compulsive disorder 2.3 1.5 0.53
Osteoarthritis 1.5 0.6 1.5
Osteoporosis 1.4 0.6 1.33
pancreatic cancer 0 0
Parkinson's Disease 4.1 3 0.37
Polycystic ovary syndrome 2.4 1.1 1.18
Postural orthostatic tachycardia syndrome 0 0.4 0
Premenstrual dysphoric disorder 0.6 0.1 5
primary biliary cholangitis 0.1 0.2 -1
Primary sclerosing cholangitis 0.5 1.3 -1.6
Psoriasis 1.6 1.1 0.45
rheumatoid arthritis (RA),Spondyloarthritis (SpA) 3.4 1.6 1.13
Rosacea 0.7 0.3 1.33
Schizophrenia 3 1.4 1.14
scoliosis 0.9 0.2 3.5
sensorineural hearing loss 0.1 0.1
Sjögren syndrome 1 1.2 -0.2
Sleep Apnea 0.9 1.1 -0.22
Slow gastric motility / Gastroparesis 0.9 0.2 3.5
Small Intestinal Bacterial Overgrowth (SIBO) 1 0.6 0.67
Stress / posttraumatic stress disorder 1.6 1.8 -0.13
Systemic Lupus Erythematosus 1.6 1.4 0.14
Tic Disorder 0.1 0.5 -4
Tourette syndrome 0 0.1 0
Type 1 Diabetes 1.6 2.1 -0.31
Type 2 Diabetes 3.6 2.9 0.24
Ulcerative colitis 2.7 2.3 0.17
Unhealthy Ageing 1.3 1 0.3
Vitiligo 0.6 0.7 -0.17

Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.

Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served.   Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 Β§β€―1030, CETS No.185, CFAA   Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license.   Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models.   Inventions /Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]